TransMolecular, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TransMolecular, Inc. - overview
Established
1996
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
TransMolecular is a biotechnology company based in Massachusetts, US. It focuses on developing and commercializing novel and proprietary drugs to diagnose and treat human cancers having inadequate pharmaceutical alternatives.
Current Investors
Pacific Horizon Ventures, Tullis Health Investors, TVM Capital Life Science
Primary Industry
Biotechnology
Sub Industries
Biopolymers, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.